Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06247813 · ClinicalTrials.gov registry record · Phase 2
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
A Phase 2 study of Chronic Pain, sponsored by Ethos Research & Development.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06247813: Recruiting Phase 2 study of Chronic Pain, sponsored by Ethos Research & Development.
NCT06247813 is a Phase 2 study of Chronic Pain that is actively recruiting participants, run by Ethos Research & Development. The registered enrollment target is 75 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06247813, a Phase 2 study of Chronic Pain, is actively recruiting participants, sponsored by Ethos Research & Development.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to use pain-specific urine biomarkers to evaluate how daily nutritional supplementation with biomarker guided formulas effect, quality of life and urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided supplementation on pain specific biomarkers through changes in urinary biomarker scores may solidify the necessity for identifying deficiencies to create an individualized treatment plan for pain patients. This study aims to evaluate the effect of biomarker-guided supplementation on the three categories of urinary biomarkers using targeted ingredients specifically designed for oxidative stress, inflammation, and nerve health. This study provides subjects with one of three nutritional supplement formulas based on their specific urinary biomarker test results and assesses changes in their urinary biomarker levels and their quality of life as it relates to their pain over a 3-month period.
Primary Outcome
Quantitative urine biomarker levels after 1 and 3 months of supplementation.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Inflammation Support Formula
- DIETARY_SUPPLEMENT Nerve Health Formula
- DIETARY_SUPPLEMENT Redox Support Formula
Study Locations (1)
Kentucky
- Ethos Research and Development - Newport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-02-08 |
| Est. Completion | 2025-07-30 |
| Phase | Phase 2 |
What NCT06247813 shows while recruiting
NCT06247813 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Inflammation Support Formula is the first listed.
NCT06247813 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06247813 about?
NCT06247813 is a clinical study titled "Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain". The goal of this study is to use pain-specific urine biomarkers to evaluate how daily nutritional supplementation with biomarker guided formulas effect, quality of life and urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided supplementation on pain specific bi...
What is the current status of trial NCT06247813?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2024-02-08. Estimated completion is 2025-07-30.
What conditions does trial NCT06247813 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT06247813?
The interventions under investigation include: Inflammation Support Formula (DIETARY_SUPPLEMENT), Nerve Health Formula (DIETARY_SUPPLEMENT), Redox Support Formula (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06247813?
This trial is sponsored by Ethos Research & Development, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06247813 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06247813's enrollment target sits among peer trials
75 159th of 301 higher than 140 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product
RECRUITING · Phase 2
-
The Role of Brain Dopamine in Chronic Pain
RECRUITING · Phase 2
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
RECRUITING · Phase 2
-
A Mobile Intervention to Reduce Pain and Improve Health-III
RECRUITING · Phase 2
-
Dronabinol as an Adjunct for Reducing Pain
RECRUITING · Phase 2
-
Palmitoylethanolamide for Chronic Inflammatory Pain Conditions
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI